PATIENT AND PHYSICIAN SATISFACTION OF TREATMENT WITH ECULIZUMAB OR RAVULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM A REAL-WORLD DISEASE-SPECIFIC PROGRAMME

被引：0
|
作者：
Fureder, W. [1 ]
Mellor, J. [2 ]
Earl, L. [2 ]
Wang, A. [3 ]
Patel, Y. [1 ,3 ]
Myren, K. J. [1 ,3 ]
Nagalla, S. [4 ]
机构：
[1] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med I, Vienna, Austria
[2] Adelphi Real World, Bollington, England
[3] Alexion, Boston, MA USA
[4] Miami Canc Inst, Benign Hematol, Miami, FL USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR187
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [21] Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand
    Anderson, P.
    Benford, M.
    Harris, N.
    Karavali, M.
    Piercy, J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3063 - 3072
  • [22] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise H.
    Duh, Mei Sheng
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4461 - 4479
  • [23] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Wendy Y. Cheng
    Sujata P. Sarda
    Nikita Mody-Patel
    Sangeeta Krishnan
    Mihran Yenikomshian
    Malena Mahendran
    Dominique Lejeune
    Louise H. Yu
    Mei Sheng Duh
    [J]. Advances in Therapy, 2021, 38 : 4461 - 4479
  • [24] Healthcare resource utilization from OPERA: A real-world study of pegcetacoplan treatment in US adults with paroxysmal nocturnal hemoglobinuria
    Fishman, Jesse
    Min, Jinny
    Arnett, Lily
    Shenoy, Apeksha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 543 - 544
  • [25] Interim Analysis of Safety Outcomes during Treatment with Eculizumab: Results from the International Paroxysmal Nocturnal Hemoglobinuria Registry
    Hill, Anita
    Roeth, Alexander
    Socie, Gerard
    Caby-Tosi, Marie-Pierre
    Wilson, Amanda
    Gustovic, Philippe
    Bedrosian, Camille L.
    Brodsky, Robert A.
    [J]. BLOOD, 2017, 130
  • [26] Real-World Use of Therapeutic Anticoagulation in Patients with Paroxysmal Nocturnal Hemoglobinuria. Results of a Survey of Physicians in Australia
    Szer, Jeffrey
    Forsyth, Cecily J.
    Giese, Anja
    [J]. BLOOD, 2015, 126 (23)
  • [27] One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment
    Kulasekararaj, A.
    Mitchell, L.
    Hill, A.
    Langemeijer, S.
    Wells, R.
    Gonzalez Fernandez, F. A.
    Gaya, A.
    Gutierrez, O.
    Piatek, C.
    Usuki, K.
    Bosi, A.
    Brodsky, R.
    Ogawa, M.
    Yu, J.
    Ortiz, S.
    Roeth, A.
    Lee, J. W.
    de la Tour, R. Peffault
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 138 - 139
  • [28] One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment
    Roeth, A.
    Kulasekararaj, A. G.
    Hill, A.
    Langemeijer, S.
    Wells, R.
    Gonzalez Fernandez, F. A.
    Gaya, A.
    Ojeda Gutierrez, E.
    Piatek, C. I.
    Mitchell, L.
    Usuki, K.
    Bosi, A.
    Brodsky, R.
    Ogawa, M.
    Yu, J.
    Ortiz, S.
    Lee, J. W.
    de la Tour, Peffault R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 173 - 174
  • [29] One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment
    Kulasekararaj, Austin
    Hill, Anita
    Langemeijer, Saskia
    Wells, Richard A.
    Gonzalez-Fernandez, F. Ataulfo
    Gaya, Anna
    Gutierrez, Emilio Ojeda
    Piatek, Caroline I.
    Mitchell, Lindsay D.
    Usuki, Kensuke
    Bosi, Alberto
    Brodsky, Robert A.
    Ogawa, Masayo
    Yu, Ji
    Ortiz, Stephan
    Roth, Alexander
    Lee, Jong-Wook
    de Latour, Regis Peffault
    [J]. BLOOD, 2019, 134
  • [30] PATIENT-REPORTED OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION BEFORE AND DURING TREATMENT WITH ECULIZUMAB: RESULTS FROM THE INTERNATIONAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA REGISTRY
    Muus, P.
    Langemeijer, S.
    Hoechsmann, B.
    Hill, A.
    Arnold, L.
    Tjonnfjord, G.
    Donato, B.
    Gustovic, P.
    Wilson, A.
    Szer, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 125 - 126
12345